Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

August 31, 2005

Conditions
Chronic Pain
Interventions
DRUG

Oxymorphone Extended Release

Trial Locations (31)

16602

Keystone Medical Research, Altoona

19053

Feasterville Family Health Center, Feasterville

19426

Perkiomen Valley Family Practice, Collegeville

19522

Fleetwood Clinical Research, Fleetwood

19702

Glasgow Family Practice, Newark

27103

Piedmont Anesthesia, Winston-Salem

29576

Waccamaw Pain Management, Murrells Inlet

30338

Comprehensive Neurology Specialists, Atlanta

Comprehensive Neuroscience, Atlanta

32114

Radiant Research, Daytona Beach

32117

Century Clinical Research, Holly Hill

32720

University Clinical Research, DeLand

33324

Park Place Therapeutic Center, Plantation

33781

Radiant Research, Pinellas Park

33907

LCFP Inc., Fort Myers

34474

Ocala Rheumatology Research Center, Ocala

34684

The Arthritis Center, Palm Harbor

35023

Southern Drug Research, Hueytown

60527

Pain Specialists of Greater Chicago, Burr Ridge

63141

Radiant Research, St Louis

64132

Research Medical Center, Kansas City

66211

Mid-America Physiatrists, Overland Park

73109

Health Research Institute, Oklahoma City

75080

KRK Medical Research, Richardson

80909

Express Care Clinical Research, Colorado Springs

84124

Jean Brown Research, Salt Lake City

85015

Phoenix Center for Clinical Research, Phoenix

85023

Arizona Research, Phoenix

97401

Pain Consultants of Oregon, Eugene

08009

Comprehensive Clinical Research, Berlin

02920

Paragon Clinical Research, Cranston

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY